Across much of the South and Midwest, the combination of high obesity prevalence, lower wages, and limited insurance coverage creates what could be described as GLP-1 deserts regions where access is constrained not just by price, but by insurance exclusions and state-level policy decisions
Their marketing references 503A and 503B certified pharmacy partners, but the FDAs April 2026 clarification means compounded semaglutide can only legally come from 503A pharmacies right now
This is approximately 3.3 million adults in Great Britain (53.7 million adults 96.0% not used medication to support weight loss in the past year 6.5%), of whom around 1.3 million (53.7 million 96.0% 2.5%) are very likely to consider it
RenewMD offers tirzepatide injections and other weight loss treatments for qualifying patients
What Is the Link Between GLP-1 Agonists and Vision Loss
The donation process itself is a bit more involved than giving whole blood